Sociodemographic Factors Associated With Gonorrhea and Chlamydia Infection in Pregnancy.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
11
8
2022
medline:
14
10
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
We explored the impact of maternal sociodemographic parameters on the prevalence of chlamydial and gonorrheal infection in pregnancy in a large United States population of live births. Retrospective analysis of the Centers for Disease Control and Prevention Natality Live Birth database (2016-2019). We compared pregnancies complicated by maternal infection with either gonorrhea or chlamydia to those without gonorrheal or chlamydial infection, separately. Both analyses included assessment of multiple maternal sociodemographic factors, which were compared between the 2 groups. Multivariable logistic regression was performed to evaluate the association of these factors with gonorrheal or chlamydial infection in pregnancy. Of the 15,341,868 included live births, 45,639 (0.30%) were from patients who had gonorrheal infection, and 282,065 (1.84%) were from patients who had chlamydial infection during pregnancy. Concurrent infection with chlamydia and gonorrhea was associated with the highest risk of gonorrhea and chalmydia in pregnancy (adjusted odds ratio, 26.28; 95% confidence interval, 25.74-26.83, and adjusted odds ratio, 26.03; 95% confidence interval, 25.50-26.58, respectively). Young maternal age, low educational attainment, non-Hispanic Black race/ethnicity, concurrent infection with syphilis, and tobacco use were also associated with a substantial increase in the risk of gonorrheal and chlamydial infection in pregnancy. Several sociodemographic factors including young maternal age, low educational attainment, Medicaid insurance, and non-Hispanic Black race/ethnicity, are associated with a marked increase in the risk for gonorrheal and chlamydial infection in current US pregnancies. These data may be used to better screen, educate, and treat pregnancies of vulnerable populations at risk for such infections.
Sections du résumé
BACKGROUND
We explored the impact of maternal sociodemographic parameters on the prevalence of chlamydial and gonorrheal infection in pregnancy in a large United States population of live births.
METHODS
Retrospective analysis of the Centers for Disease Control and Prevention Natality Live Birth database (2016-2019). We compared pregnancies complicated by maternal infection with either gonorrhea or chlamydia to those without gonorrheal or chlamydial infection, separately. Both analyses included assessment of multiple maternal sociodemographic factors, which were compared between the 2 groups. Multivariable logistic regression was performed to evaluate the association of these factors with gonorrheal or chlamydial infection in pregnancy.
RESULTS
Of the 15,341,868 included live births, 45,639 (0.30%) were from patients who had gonorrheal infection, and 282,065 (1.84%) were from patients who had chlamydial infection during pregnancy. Concurrent infection with chlamydia and gonorrhea was associated with the highest risk of gonorrhea and chalmydia in pregnancy (adjusted odds ratio, 26.28; 95% confidence interval, 25.74-26.83, and adjusted odds ratio, 26.03; 95% confidence interval, 25.50-26.58, respectively). Young maternal age, low educational attainment, non-Hispanic Black race/ethnicity, concurrent infection with syphilis, and tobacco use were also associated with a substantial increase in the risk of gonorrheal and chlamydial infection in pregnancy.
CONCLUSIONS
Several sociodemographic factors including young maternal age, low educational attainment, Medicaid insurance, and non-Hispanic Black race/ethnicity, are associated with a marked increase in the risk for gonorrheal and chlamydial infection in current US pregnancies. These data may be used to better screen, educate, and treat pregnancies of vulnerable populations at risk for such infections.
Identifiants
pubmed: 35948286
doi: 10.1097/OLQ.0000000000001688
pii: 00007435-202211000-00004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
750-754Informations de copyright
Copyright © 2022 American Sexually Transmitted Diseases Association. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest and Sources of Funding: None declared.
Références
Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1545–1602.
Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull World Health Organ 2019; 97:548–562P.
Sexually transmitted disease surveillance 2019. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/std/statistics/2019/default.htm . Accessed March 2, 2022.
Gregory ECW, Ely DM. Trends and characteristics of sexually transmitted infections during pregnancy: United States, 2016–2018. Natl Vital Stat Rep 2020; 69:1–11.
Andrews WW, Goldenberg RL, Mercer B, et al. The preterm prediction study: Association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183:662–668.
Alger LS, Lovchik JC, Hebel JR, et al. The association of Chlamydia trachomatis , Neisseria gonorrhoeae , and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988; 159:397–404.
He W, Jin Y, Zhu H, et al. Effect of chlamydia trachomatis on adverse pregnancy outcomes: A meta-analysis. Arch Gynecol Obstet 2020; 302:553–567.
Gao R, Liu B, Yang W, et al. Association of maternally sexually transmitted infections with risk of preterm birth in the United States. JAMA Netw Open 2021; 4:e2133413.
Schachter J, Grossman M, Sweet RL, et al. Prospective study of perinatal transmission of Chlamydia trachomatis . JAMA 1986; 255:3374–3377.
Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin Infect Dis 2011; 53(Suppl 3):S99–S102.
Tsevat DG, Wiesenfeld HC, Parks C, et al. Sexually transmitted diseases and infertility. Am J Obstet Gynecol 2017; 216:1–9.
Davidson KW, Barry MJ, Mangione CM, et al. Screening for chlamydia and gonorrhea: US preventive services task force recommendation statement. JAMA 2021; 326:949–956.
Hogben M, Leichliter JS. Social determinants and sexually transmitted disease disparities. Sex Transm Dis 2008; 35(12 Suppl):S13–S18.
Centers for Disease Control and Prevention. CDC Wonder Natality Information: Natality for 2016–2019 (expanded). Available at: https://wonder.cdc.gov/natality-expanded-current.html . Accessed September 23, 2021.
Centers for Disease Control and Prevention. CDC Wonder Data Use Restrictions. Available at: https://wonder.cdc.gov/DataUse.html . Accessed February 24, 2022.
Goggins ER, Chamberlain AT, Kim TG, et al. Patterns of screening, infection, and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnancy. Obstet Gynecol 2020; 135:799–807.
Lazenby GB, Savage AH, Horner G, et al. Declining chlamydia and gonorrhea diagnoses among pregnant women in South Carolina, 2008 to 2018. Sex Transm Dis 2021; 48:141–144.
Waltmann A, McKinnish TR, Duncan JA. Nonviral sexually transmitted infections in pregnancy: Current controversies and new challenges. Curr Opin Infect Dis 2021; 34:40–49.
Grant JS, Chico RM, Lee AC, et al. Sexually transmitted infections in pregnancy: A narrative review of the global research gaps, challenges, and opportunities. Sex Transm Dis 2020; 47:779–789.
Nyemba DC, Medina-Marino A, Peters RPH, et al. Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa. Sex Transm Infect 2021; 97:375–381.
Yeganeh N, Kreitchmann R, Leng M, et al. High prevalence of sexually transmitted infections in pregnant women living in Southern Brazil. Sex Transm Infect 2021; 48:128–133.
Op de Coul ELM, Peek D, van Weert YWM, et al. Chlamydia trachomatis , Neisseria gonorrhoeae , and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes. Reprod Health 2021; 18:132.
Niles JK, Kaufman HW, Peterman TA, et al. Chlamydia trachomatis and Neisseria gonorrhoeae in pregnancy: Trends in United States, 2010 to 2018. Sex Transm Dis 2021; 48:932–938.